Status:
UNKNOWN
Effect of Significant Ischemic Mitral Regurgitation on the Outcome of ST Segment Elevation Myocardial Infarction Patients Treated With Primary Percutaneous Coronary Intervention
Lead Sponsor:
Assiut University
Conditions:
Ischemic Mitral Regurgitation
Eligibility:
All Genders
Brief Summary
The goal of the study is to correlate the effect of ischemic mitral regurgitation on the outcome of STEMI patients treated with successful primary PCI using clinical data and echocardiography on prese...
Detailed Description
* IMR is defined as mitral regurgitation (MR) caused by chronic changes of LV structure and function due to ischemic heart disease. It is not a valve disease but represents the valvular consequences o...
Eligibility Criteria
Inclusion
- Subjects with first presentation
- Subjects with Acute STEMI
- Subjects undergoing Primary PCI with Successful reperfusion
- Subjects with significant IMR Grade (III/IV) to (IV/IV)
- Subjects with acute STEMI with no or non-significant MR undergoing Primary PCI undergoing primary PCI with successful reperfusion (as control)
Exclusion
- Rheumatic mitral regurge
- Valvular mitral regurge
- IMR Grade (II/IV)
- Cardiomyopathies
- Associated other valvular heart diseases
Key Trial Info
Start Date :
November 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 20 2023
Estimated Enrollment :
134 Patients enrolled
Trial Details
Trial ID
NCT04106648
Start Date
November 1 2020
End Date
September 20 2023
Last Update
January 22 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.